BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
2.770
+0.030 (1.09%)
At close: Jun 12, 2026, 4:00 PM EDT
2.780
+0.010 (0.36%)
After-hours: Jun 12, 2026, 5:43 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$1,917,204
Market Cap
23.92M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% | 16 | 0 |
| Jul 31, 2021 | 6 | 0 | - | 5 | 1 |
| Aug 1, 2019 | 6 | - | - | 5 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Kyntra Bio | 34 |
| NeuroSense Therapeutics | 17 |
| Quantum BioPharma | 17 |
| Serina Therapeutics | 16 |
| CervoMed | 15 |
| Skye Bioscience | 12 |
| Tvardi Therapeutics | 12 |
BCTX News
- 10 days ago - BriaCell Therapeutics Announces Closing of Offering - GlobeNewsWire
- 11 days ago - BriaCell Presents Positive Clinical Data at ASCO 2026 - GlobeNewsWire
- 11 days ago - BriaCell Therapeutics Announces Pricing of Offering - GlobeNewsWire
- 17 days ago - BriaCell (BCTX) Receives Positive Update from Data Safety Monitoring Board - GuruFocus
- 17 days ago - BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study - TheFly
- 17 days ago - BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer - GlobeNewsWire
- 21 days ago - BriaCell (BCTX) Unveils Key Clinical Data at ASCO Annual Meeting 2026 - GuruFocus
- 21 days ago - BriaCell announces data from Bria-IMT at ASCO 2026 - TheFly